(Q35826385)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Pharmacokinetics of oral fumarates in healthy subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Rik C Schoemaker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

2

Jacobus Burggraaf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Elisabeth van Strijen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Co van Gulpen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Herman Mattie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jaap T van Dissel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

H Bing Thio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Peter H Nibbering

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Clinical Pharmacology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

429-432

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

A systematic review of treatments for severe psoriasis

1 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884599

Cyclosporine: what clinicians need to know.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884599

Fumaric acid therapy in psoriasis: a double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid ester.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884599

Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884599

Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884599

Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokines

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884599

Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference

24 September 2018

1 reference

12 December 2020

[Treatment of psoriasis vulgaris.]

1 reference

12 December 2020

Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy

1 reference

12 December 2020

1 reference

12 December 2020

Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy

1 reference

12 December 2020

Fumaric acid therapy for psoriasis: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Fumaric acid therapy in psoriasis: results and side effects of 2 years of treatment

1 reference

12 December 2020

Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients

1 reference

12 December 2020

Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study

1 reference

12 December 2020

10.1111/J.1365-2125.2004.02145.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15373936%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

PubMed publication ID

15373936

1 reference